Nicotine Mae (Nicotine Resinate)

Nicotine resinate binds to nicotinic acetylcholine receptors in the brain, stimulating them in a manner similar to nicotine from tobacco. This receptor activation reduces the intensity of withdrawal symptoms and the urge to smoke, supporting the cessation process.

The specific dose of Nicotine Mae is determined by the prescribing healthcare professional based on the individual’s smoking history, health status, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety in pregnancy and lactation has not been fully established. Use only if the potential benefit justifies any possible risk to the fetus or infant, and discuss the decision with a qualified healthcare provider.

Enquiries can be submitted on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Nicotine Mae provides nicotine receptor stimulation similar to other nicotine replacement therapies (NRT) such as patches or gum, but in an oral dosage form. Compared with non‑nicotine medications, it directly addresses nicotine cravings, while non‑nicotine agents work through different neurotransmitter pathways.

Store Nicotine Mae at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Nicotine Mae is taken orally as directed by a healthcare professional. The tablet (or oral formulation) should be swallowed with water, typically at scheduled intervals, and should not be chewed or dissolved unless specifically instructed.

Serious risks include severe allergic reactions (anaphylaxis), chest pain or palpitations, and significant cardiovascular effects such as hypotension or arrhythmia. Patients should seek immediate medical attention if any of these symptoms occur.

Individuals with uncontrolled hypertension, recent myocardial infarction, severe cardiac arrhythmias, or known hypersensitivity to nicotine resinate should avoid using Nicotine Mae. Additionally, patients using other nicotine replacement products concurrently should not combine therapies without medical guidance.